Pages that link to "Q40232312"

The following pages link to Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort (Q40232312):

Displaying 29 items.

• Disability in Patients with Inflammatory Bowel Disease: Correlations with Quality of Life and Patient's Characteristics (Q33786688) (← links)
• Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases (Q37521805) (← links)
• Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases (Q37656035) (← links)
• Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis (Q38752119) (← links)
• Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease (Q38797791) (← links)
• A review of endoscopic balloon dilatation techniques for treating Crohn's strictures: time to standardise therapy (Q38842454) (← links)
• Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients (Q39497018) (← links)
• The Rating Form of IBD Patient Concerns: Translation, Validation, and First Implementation of the Greek Version. (Q42280534) (← links)
• Disability Index as a New Outcome Measure in Patients with Inflammatory Bowel Disease (Q42355011) (← links)
• Preventing disability in inflammatory bowel disease (Q45338711) (← links)
• Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis (Q46476404) (← links)
• Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index. (Q48218369) (← links)
• Quality of care in inflammatory bowel diseases: What is the best way to better outcomes? (Q55078576) (← links)
• Inflammatory bowel disease registries for collection of patient iron parameters in Europe. (Q55100618) (← links)
• Medication non-adherence in inflammatory bowel diseases is associated with disability (Q57284262) (← links)
• Treat-to-target in Crohn's disease: Will transmural healing become a therapeutic endpoint? (Q58551550) (← links)
• Cultural Adaptation and Validation of the Inflammatory Bowel Disease Disability Index in a Spanish Population and Its Association with Sociodemographic and Clinical Factors (Q64119635) (← links)
• Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel disease (Q64267286) (← links)
• Efficacy and Safety of Vonoprazan-Based versus Proton Pump Inhibitor-Based Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Clinical Trials. (Q64911071) (← links)
• Ulcerative colitis (Q88899916) (← links)
• Objective evaluation for treat to target in Crohn's disease (Q90042392) (← links)
• Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients (Q90150407) (← links)
• Systematic review of development and content validity of patient-reported outcome measures in Inflammatory Bowel Disease: do we measure what we measure? (Q90646038) (← links)
• Evolving therapeutic goals in Crohn's disease management (Q90656808) (← links)
• The introduction of the IBD Disk in Poland - a new tool for assessing disability in patients with inflammatory bowel disease (Q90671473) (← links)
• Time to include patients with ulcerative proctitis in clinical trials (Q91160311) (← links)
• Protocol of a multicentric prospective cohort study for the VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases: the VALIDate study (Q91994253) (← links)
• A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review (Q92597348) (← links)
• Ulcerative colitis (Q99349994) (← links)